FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | H 股份類別 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02120 | 說明 H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2025年9月15日 | 19,598,900 | | 0 | | 19,598,900 | | 1). 其他 (請註明) | | | % | | | | | 見B部 | | | | | | | ...

Group 1 - The company, 康宁医院, announced a share buyback plan, intending to repurchase 13,500 shares at a total cost of HKD 15.255 million [1]

Core Viewpoint - Corning Hospital (02120) announced a share buyback plan, intending to repurchase 13,500 shares at a cost of HKD 15.255 million by September 15, 2025 [1] Company Summary - The company plans to utilize HKD 15.255 million for the repurchase of shares, indicating a strategic move to enhance shareholder value [1] - The buyback involves a total of 13,500 shares, reflecting the company's commitment to returning capital to its shareholders [1]

公司名稱： 溫州康寧醫院股份有限公司 呈交日期： 2025年9月15日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 H | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02120 | H股 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 ...

格隆汇9月12日丨康宁医院(02120.HK)公告，9月12日耗资23.2万港元回购2.1万股。 ...

Group 1 - The company, 康宁医院, announced a share buyback plan, repurchasing approximately 20,600 shares at a cost of about HKD 232,100 on September 12, 2025 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 溫州康寧醫院股份有限公司 呈交日期： 2025年9月12日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02120 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | ...

Summary of Key Points Core Viewpoint - Multiple companies conducted share buybacks on September 11, 2025, with Tencent Holdings leading in both the number of shares repurchased and the total amount spent [1][2]. Company Buyback Details - Tencent Holdings (00700) repurchased 874,000 shares for a total of 550 million, with a year-to-date total of 54.758 million shares, representing 0.596% of its total share capital [2]. - Hang Seng Bank (00011) repurchased 210,000 shares for 24.882 million, with a year-to-date total of 6.12 million shares, representing 0.325% of its total share capital [2]. - Stone Four Pharmaceutical Group (02005) repurchased 6 million shares for 18.1433 million, with a year-to-date total of 22.6 million shares, representing 0.766% of its total share capital [2]. - MGM China (02282) repurchased 1 million shares for 16.2463 million, with a year-to-date total of 18.6274 million shares, representing 0.490% of its total share capital [2]. - Other notable companies include: - China Hongqiao (01378) with 100,500 shares repurchased for 2.4636 million, totaling 149 million shares, representing 1.590% of its total share capital [2]. - Weigao Group (01066) with 429,200 shares repurchased for 2.4248 million, totaling 10.4532 million shares, representing 2.315% of its total share capital [2]. - Coolpad Group (02369) with 924,000 shares repurchased for 1.2036 million, totaling 1.2519 million shares, representing 3.057% of its total share capital [2].

康宁医院(02120)发布公告，于2025年9月11日斥资28.57万港元回购2.59万股股份。 ...

Group 1 - The company, 康宁医院, announced a share buyback plan, intending to repurchase 25,900 shares at a cost of HKD 285,700 [1] - The share buyback is scheduled to take place on September 11, 2025 [1] - This move indicates the company's strategy to enhance shareholder value through capital management [1]